Posts tagged AMRN


Company Update (NASDAQ:AMRN): Amarin Corporation plc Provides Preliminary 2017 Results and Provides 2018 Outlook

Amarin Corporation plc (NASDAQ:AMRN) provided a business update, including an update on 2017 revenue guidance, …

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Announces 3Q:17 Financial Results and Provides Update on Operations

Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced financial results for the three and nine months ended September …

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) and HLS Therapeutics Announce Agreement to Commercialize Vascepa in Canada

Amarin Corporation plc (ADR) (NASDAQ:AMRN) and HLS Therapeutics Inc. (“HLS”), announced today an exclusive agreement …

Stock Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Appoints Mark W. Salyer to New Position of Chief Commercial Officer

Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that Mark W. Salyer has joined Amarin as Chief Commercial Officer. …

Novartis’ Data Offers Insights into Amarin Corporation plc’s (ADR) (AMRN) REDUCE-IT Trial

Novartis’ Results Could Be a Good Looking Glass into Successful Commercial Future for Amarin

Amarin Corporation plc (ADR) (AMRN) Announces 2Q:17 Financial Results; Shares Jump 9%

Amarin Corporation plc (NASDAQ:AMRN) announced financial results for the three and six months ended June 30, …

Cantor Pounds The Table On Amarin Corporation plc (ADR) (AMRN)

Cantor analyst Louise Chen was out pounding the table on shares of Amarin Corporation plc …

Amarin Corporation plc (ADR) (AMRN) Announces Two EPA-Related Data Presentations

Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced two EPA-related data presentations unveiled this week at the …

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Shares Surge 3% Following 4Q Results

Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced financial results for the quarter and year ended December …

Show More